Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Hepatitis

Free Subscription Articles published in Cancer Retrieve available abstracts of 17 articles: HTML format

Single Articles

February 2021
1. SHALTIEL T, Zheng S, Siderides C, Gleeson EM, et al
   Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
   Cancer. 2021 Feb 25. doi: 10.1002/cncr.33377.
   PubMed     Abstract available
   
   
   September 2020
2. LI M, Sack JS, Rahma OE, Hodi FS, et al
   Outcomes after resumption of immune checkpoint inhibitor therapy after high-grade immune-mediated hepatitis.
   Cancer. 2020 Sep 5. doi: 10.1002/cncr.33165.
   PubMed     Abstract available
   
   
   May 2020
3. LIU Z, Suo C, Mao X, Jiang Y, et al
   Global incidence trends in primary liver cancer by age at diagnosis, sex, region, and etiology, 1990-2017.
   Cancer. 2020;126:2267-2278.
   PubMed     Abstract available
   
   
   April 2019
4. SHIELS MS, Engels EA, Yanik EL, McGlynn KA, et al
   Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
   Cancer. 2019 Apr 12. doi: 10.1002/cncr.32129.
   PubMed     Abstract available
   
   
   April 2018
5. YI SW, Choi JS, Yi JJ, Lee YH, et al
   Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.
   Cancer. 2018 Apr 18. doi: 10.1002/cncr.31406.
   PubMed     Abstract available
   
   
   
6. KIM NG, Nguyen PP, Dang H, Kumari R, et al
   Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
   Cancer. 2018 Apr 6. doi: 10.1002/cncr.31373.
   PubMed     Abstract available
   
   
   
7. FANG DM, Stewart SL
   Social-cultural, traditional beliefs, and health system barriers of hepatitis B screening among Hmong Americans: A case study.
   Cancer. 2018;124 Suppl 7:1576-1582.
   PubMed     Abstract available
   
   
   February 2018
8. KANTARJIAN HM, Paul S
   Hepatitis C: When high drug prices preclude patient benefit.
   Cancer. 2018 Feb 27. doi: 10.1002/cncr.31292.
   PubMed    
   
   
   
9. SORIANO V, Tefferi A
   Prevention of liver cancer with new curative hepatitis C antivirals: Real-world challenges.
   Cancer. 2018 Feb 27. doi: 10.1002/cncr.31291.
   PubMed    
   
   
   November 2017
10. ECONOMIDES MP, Amit M, Mahale PS, Hosry JJ, et al
    Impact of chronic hepatitis C virus infection on the survival of patients with oropharyngeal cancer.
    Cancer. 2017 Nov 17. doi: 10.1002/cncr.31146.
    PubMed     Abstract available
    
    
    
11. MA GX, Lee MM, Tan Y, Hanlon AL, et al
    Efficacy of a community-based participatory and multilevel intervention to enhance hepatitis B virus screening and vaccination in underserved Korean Americans.
    Cancer. 2017 Nov 13. doi: 10.1002/cncr.31134.
    PubMed     Abstract available
    
    
    July 2017
12. STUDAWAY A, Ojha RP, Brinkman TM, Zhang N, et al
    Chronic hepatitis C virus infection and neurocognitive function in adult survivors of childhood cancer.
    Cancer. 2017 Jul 25. doi: 10.1002/cncr.30913.
    PubMed     Abstract available
    
    
    June 2017
13. LIN YY, Yu MW, Lin SM, Lee SD, et al
    Genome-wide association analysis identifies a GLUL haplotype for familial hepatitis B virus-related hepatocellular carcinoma.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30851.
    PubMed     Abstract available
    
    
    
14. JOHNSON DB, Sullivan RJ, Menzies AM
    Immune checkpoint inhibitors in challenging populations.
    Cancer. 2017;123:1904-1911.
    PubMed     Abstract available
    
    
    May 2017
15. HWANG JP, Suarez-Almazor ME, Cantor SB, Barbo A, et al
    Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Cancer. 2017 May 18. doi: 10.1002/cncr.30729.
    PubMed     Abstract available
    
    
    
16. LV JW, Chen YP, Huang XD, Zhou GQ, et al
    Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Cancer. 2017 May 10. doi: 10.1002/cncr.30775.
    PubMed     Abstract available
    
    
    December 2016
17. MOUKHADDER HM, Halawi R, Cappellini MD, Taher AT, et al
    Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30462.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: